PHARMACEUTICAL COMPOSITION FOR TREATING OVERACTIVE BLADDER

摘要

It is intended to provide a pharmaceutical composition useful as a therapeutic agent for overactive bladder. The pharmaceutical composition containing (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl}acetanilide or a pharmaceutically acceptable salt thereof and (3R)-quinuclidin-3-yl-(1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate or a pharmaceutically acceptable salt thereof as active ingredients and particularly for improving symptoms accompanying overactive bladder such as urgency of urination, frequent urination, and/or urinary incontinence.